Skip to:

Sheena G. Sullivan

Adjunct Assistant Professor


DepartmentsType of Faculty
EpidemiologyPart Time
Contact Information
Areas of Interest: 

Dr Sullivan currently works with the WHO Collaborating Centre for Reference and Research on Influenza in Melbourne, Australia.  This is one of 5 centres around the world tasked with influenza virological surveillance for the purpose of informing vaccine development.  She is the first epidemiologist to work the Melbourne Centre and a core function of this position is to expand epidemiology research at the Centre and provide epidemiological support to countries in the Asia-Pacific region. 

Her primary focus has been on using sentinel influenza surveillance data from around Australia to estimate influenza vaccine effectiveness and to understand the validity of the methods used to conduct these studies.  Lately, many research groups have used the test-negative study design to estimate vaccine effectives, but it is relatively new and its potential for bias is poorly understood.  Thus, she is working with an international network of epidemiologists who studying its validity.  She is also interested in improving influenza surveillance methods, particularly for tropical countries where seasonality is less-well defined.  With the US CDC she has co-facilitated training on the collection and management of influenza surveillance data for heath departments in developing countries of South and Southeast Asia.  She is also attends meetings of the Australian Influenza Surveillance Strategy Working Group which advises the Communicable Diseases Network of Australia on influenza surveillance.


Dr. Sheena Sullivan is an infectious diseases epidemiologist.  She completed an MPH at the University of Western Australia in 2002 and her PhD in 2011 at UCLA.  She worked for several years with the Chinese Centre for HIV/STD Prevention and Control in Beijing, where her work focussed on understanding stigma towards people with HIV and methadone treatment outcomes.  As a student, she worked briefly with the United Nations Office on Drugs and Crime in Tehran, and the International Agency for Research on Cancer, Lyon, France.